Chasing an update on performance pre 2017/18 Half Year announcement.
Notice in any recent announcements that no 2017/18 Budget figures are shown.
Asset revaluation may be the hope.
History shows,
Sales Rev
- 2015/16 $16.0m
- 2016/17 $23.8m
Gross Margin - %
- 2015/16 46%
- 2016/17 30%
EBITDA
- 2015/16 - loss 2.3m
- 2016/17 - loss 9.7m
NPAT
- 2015/16 - loss 1.7m
- 2016/17 - loss 7.7m
Net Assets
- 2016/17 $134.1m
Asset (Land & Buildings, Stock, etc) values may be rising but are Revenues and Profits jumping. Higher asset values then greater Revenues/profits must follow to get needed ROI's.
Hard numbers - by total Company and Divisions - would be good.
Does BPAM get commissions paid on Domestic sales?? Surely Domestic has nothing to do with BPAM. Company has invested in staff to achieve/get the needed results not BPAM.
Tree trunk established but hard to see branches and leaves................................ am I missing something?
- Forums
- ASX - By Stock
- Performance
Chasing an update on performance pre 2017/18 Half Year...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BFC (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.991M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BFC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online